Senate approves $2B boost for NIH in $850B+ spending billAllbiopro2018-08-25T12:05:10+09:008월 25th, 2018|
Chutes & Ladders—Novartis brings in new CEO to clean up Korean branchAllbiopro2018-08-25T12:04:08+09:008월 25th, 2018|
uniQure starts dosing in pre-pivotal hemophilia B gene therapy trialAllbiopro2018-08-25T12:03:05+09:008월 25th, 2018|
Zai Lab cans ex-GlaxoSmithKline eczema drug after phase 2 flopAllbiopro2018-08-25T12:02:06+09:008월 25th, 2018|
Freedom of innovation: GE opens $17m Swedish biotech testing centerAllbiopro2018-08-25T12:00:56+09:008월 25th, 2018|
Closing in on mystery surrounding dangerous blood syndromesAllbiopro2018-08-25T11:58:57+09:008월 25th, 2018|
FDA approves first drug for neurotrophic keratitis, a rare eye diseaseAllbiopro2018-08-24T00:58:27+09:008월 24th, 2018|
Novartis’s Breast Cancer Drug Looks Promising in Phase III Trial, Despite Category’s Troubling HistoryAllbiopro2018-08-24T00:55:44+09:008월 24th, 2018|
AstraZeneca COPD Drug Fails to Distinguish Itself from Rival GSK TreatmentAllbiopro2018-08-24T00:54:47+09:008월 24th, 2018|
Toxic “Zombie Cells” Observed in Alzheimer’s PatientsAllbiopro2018-08-24T00:53:52+09:008월 24th, 2018|
